Status:
COMPLETED
Treatment of Atrofic Striae With Percutaneous Collagen Induction Therapy Versus Fractional Nonablative Laser
Lead Sponsor:
Hospital de Clinicas de Porto Alegre
Collaborating Sponsors:
Associação Fundo de Incentivo à Pesquisa
MTO Importadora e Distribuidora
Conditions:
Striae Distensae
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
As atrophic striae are common dermatological conditions. Various therapeutic modalities have been employed in the treatment of striae distensae, mainly in striae rubra. There are few studies that incl...
Detailed Description
Twenty patients will be treated at the dermatologic clinic of the Hospital de Clínicas de Porto Alegre (HCPA). Each patient will be treated with laser and microneedle at the same time, being applied a...
Eligibility Criteria
Inclusion
- female patients,
- age 18 and over;
- presenting with abdominal striae rubra diagnosed after clinical examination;
- patients with weight stability in the last four months;
- patients with Fitzpatrick III or IV phototype.
Exclusion
- pregnant women;
- childbirth for less than 12 months;
- history of keloid scars;
- presence of localized or systemic infection;
- presence of immunosuppression;
- use of photosensitizing medications;
- use of systemic steroids;
- use of oral isotretinoin in the last 12 months;
- history of diseases of collagen or elastic fibers;
- hypersensitivity to infiltrative or topical anesthetics;
- patients who have been treated for striae distensae in the last year;
- presence of sun exposure during the study.
Key Trial Info
Start Date :
July 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 20 2018
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03390439
Start Date
July 1 2017
End Date
April 20 2018
Last Update
August 1 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ana Paula Naspolini
Porto Alegre, Rio Grande do Sul, Brazil, 90035903